The FDA also approved Vimpat Injection for use in pediatric patients 4 years of age and older. The Food and Drug Administration (FDA) has approved Vimpat ® (lacosamide; UCB) as adjunctive therapy in ...
-- New approval for VIMPAT® (lacosamide) CV in the U.S. as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures (PGTCS) in patients four years of age and older -- All three ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. DENVER — Primary generalized tonic-clonic seizures ...
ATLANTA, June 24, 2024 /PRNewswire/ -- UCB, a global biopharmaceutical company, today announced that Epilepsia published findings from a comprehensive scoping review examining the efficacy of FINTEPLA ...
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that 24-month data on generalized tonic-clonic (GTC) seizures in people with drug-resistant epilepsy (DRE) ...
Researchers have discovered supplementing a normal, carbohydrate-rich diet with specific ketogenic agents may significantly delay tonic-clonic seizures caused by exposure to high levels of oxygen. The ...
More than 3.4 million people in the United States have epilepsy, so it is a relatively common diagnosis. In fact, it is the fourth-most common neurologic condition in the world. November is National ...
A seizure occurs when there is abnormal electrical activity in the brain. There are different types of seizures depending on where and how much brain activity is affected. If someone is seizing make ...
If you don't know anybody who has epilepsy, you probably tend to think of it in one form: big, dramatic seizures (usually brought on by flashing lights or brain tumors) that involve bodily spasms, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results